Sudhir Srivastava, M.D. 13D and 13G filings for SS Innovations International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:15 pm Purchase |
2025-03-31 | 13G | SS Innovations International, Inc. SSII |
Sudhir Srivastava, M.D. | 117,324,445 60.600% |
9,505,655 (+8.82%) |
Filing |
| 2025-02-13 4:05 pm Sale |
2024-12-31 | 13G | SS Innovations International, Inc. SSII |
Sudhir Srivastava, M.D. | 107,818,790 63.100% |
-10,280,278 (-8.70%) |
Filing |
| 2024-02-09 4:05 pm Purchase |
2023-12-31 | 13G | SS Innovations International, Inc. SSII |
Sudhir Srivastava, M.D. | 118,099,068 69.830% |
118,099,068 (New Position) |
Filing |